Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "3D Bioprinting Market by Component, Material, Application, End User, Regional Outlook - Global Forecast up to 2030" report has been added to ResearchAndMarkets.com's offering.
The worldwide 3D bioprinting market was worth USD 2.0 billion in 2022, and it is predicted to increase at a compound annual growth rate (CAGR) of 20.4% between 2023 and 2030.
The increase is attributable to a scarcity of organ donors and an ageing population with chronic respiratory disorders. Rising R&D expenditure, technological innovation, and an increase in the prevalence of chronic illnesses are all factors that are projected to drive market expansion.
The 3D printing community reacted to the COVID-19 problem by volunteering to assist in the manufacturing of critical medical equipment for hospitals dealing with the epidemic.
Key Takeaways
- This report illustrates the most vital attributes of the 3D Bioprinting Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the 3D Bioprinting Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the 3D Bioprinting Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the 3D Bioprinting Market.
Key Topics Covered:
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.4. DRO - Impact Analysis
5. Component: Market Size & Analysis
5.1. Overview
5.2. 3D Bioprinters
5.3. Bioinks
6. Application: Market Size & Analysis
6.1. Overview
6.2. Research applications
6.3. Clinical applications
7. End Users: Market Size & Analysis
7.1. Overview
7.2. Research Organizations and Academic Institutes,
7.3. Biopharmaceutical companies
7.4. Hospitals
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
- EnvisionTEC, Inc
- Organovo Holdings, Inc
- Inventia Life Science PTY LTD
- Poietis
- Vivax Bio, LLC
- Allevi
- Cyfuse Biomedical K.K
- 3D Bioprinting Solutions
- Cellink Global
- Regemat 3D S.L.
For more information about this report visit https://www.researchandmarkets.com/r/iezk8q
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
